Table 3 Characteristics of medullary thyroid carcinomas
From: Signification of forkhead box A1 (FOXA1) expression in thyroid cancers
Clinicopathological features | Patient outcome | Immunostaining results | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Case | Gender | Age | Size (cm) | Tumor stage | Recurrence | Recurrence type | Interval time to recurrence | Calcitonin | Chromogranin A | FOXA1 |
1 | F | 73 | 3.8 | II | Yes | Loco-regional | 2 years | 4+ | 4+ | 4+ |
2 | F | 34 | 3 | II | Patient lost | – | – | 4+ | 4+ | 4+ |
3 | M | 53 | 1 | I | No | – | – | 4+ | 3+ | 3+ |
4 | M | 56 | 0.3 | I | No | – | – | 3+ | 3+ | 3+ |
5 | M | 49 | 1.5 | II | No | – | – | 4+ | 3+ | 4+ |
6 | F | 66 | 3 | II | Yes | Loco-regional | 2 years | 4+ | 4+ | 4+ |
7 | M | 65 | 5 | IV | Yes | Distant | 6 months | 3+ | 4+ | 4+ |
8 | F | 70 | 2 | II | No | – | – | 3+ | 3+ | 3+ |
9 | F | 42 | 4.5 | III | Yes | Loco-regional | 18 months | 3+ | 3+ | 4+ |
10 | F | 53 | 1 | I | No | – | – | 2+ | 3+ | 3+ |
11 | M | 57 | 5.5 | IV | No | – | – | 4+ | 4+ | 4+ |
12 | F | 41 | 1 | I | No | – | – | 2+ | 2+ | 3+ |
13 | F | 65 | 3 | II | No | – | – | 4+ | 3+ | 3+ |
14 | M | 73 | 4.5 | IV | No | – | – | 4+ | 4+ | 4+ |
15 | F | 55 | 1.2 | I | No | – | – | 3+ | 4+ | 4+ |
16 | F | 58 | 2 | II | Patient lost | – | – | 3+ | 3+ | 3+ |
17 | F | 55 | 2.8 | III | No | – | – | 3+ | 3+ | 3+ |
18 | F | 53 | 2.1 | II | No | – | – | 3+ | 3+ | 3+ |